会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 34. 发明申请
    • NOVEL ANTIGEN BINDING MOLECULES FOR THERAPEUTIC, DIAGNOSTIC, PROPHYLACTIC, ENZYMATIC, INDUSTRIAL, AND AGRICULTURAL APPLICATIONS, AND METHODS FOR GENERATING AND SCREENING THEREOF
    • 用于治疗,诊断,预防,食用,工业和农业应用的新型抗原结合分子及其产生和筛选的方法
    • WO2002092780A2
    • 2002-11-21
    • PCT/US2002/015767
    • 2002-05-17
    • DIVERSA CORPORATIONSHORT, Jay, M.
    • SHORT, Jay, M.
    • C12N
    • C12N15/1093C12N15/102C12N15/1027C12N15/66
    • The invention is directed to methods for generating sets, or libraries, of nucleic acids encoding antigen-binding sites, such as antibodies, antibody domains or other fragments, including single and double stranded antibodies, major histocompatibility complex (MHC) molecules, T cell receptors (TCRs), and the like. This invention provides methods for generating variant antigen binding sites, e.g., antibodies and specific domains or fragments of antibodies (e.g., Fab or Fc domains), by altering template nucleic acids including by saturation mutagenesis, synthetic ligation reassembly, or a combination thereof. In one aspect, the invention provides methods for generating all human or humanized antibodies and evolving them to achieve optimized properties related to stability, duration, expression, production, enzymatic activity, affinity, avidity, localization, and other immunological properties. Polypeptides generated by these methods can be analyzed using a novel capillary array platform, which provides unprecedented ultra-high throughput screening.
    • 本发明涉及用于产生编码抗原结合位点的核酸(例如抗体,抗体结构域或其它片段,包括单链和双链抗体,主要组织相容性复合体(MHC)分子,T细胞受体 (TCR)等。 本发明提供了通过改变模板核酸,包括饱和诱变,合成连接重组或其组合来产生变体抗原结合位点,例如抗体和抗体的特异结构域或片段(例如,Fab或Fc结构域)的方法。 一方面,本发明提供了产生所有人源化或人源化抗体并进化出来以实现与稳定性,持续时间,表达,产生,酶活性,亲和力,亲合力,定位和其他免疫学性质相关的优化性质的方法。 通过这些方法产生的多肽可以使用新颖的毛细管阵列平台进行分析,提供前所未有的超高通量筛选。